Author

S. Bobisse

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 4 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 5 Research Focus:cell type annotation· 3 Approach:deep learning· 3 Assay:proteomics· 3 Research Focus:cell-cell communication· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Assay:scRNA-seq· 2

Frequent Co-Authors

A. Harari· 5 shared G. Coukos· 4 shared C. Sauvage· 3 shared J. Chiffelle· 3 shared M. Arnaud· 3 shared M. Bassani-Sternberg· 3 shared A. Orcurto· 2 shared D. Barras· 2 shared

Activity by Year

2019-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

5 shared papersImmunology

A. Harari

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

KIR3DL1 and Tox identify clonally expanded encephalitogenic neuron-specific CD8+ T cells in autoimmune encephalitis

S. Perriot, S. Jones, R. Genolet, A. Mathias, H. Lindsay, S. Bobisse, G. Di Liberto, M. Canales, L. Queiroz, C. Sauvage, I. Wagner, L. Oberholster, M. Gimenez, D. Begarie, M. Theaudin, , R. Du Pasquier

The paper identifies clonally expanded neuron-specific CD8+ T cells in anti-Ri AIE patients using an unbiased approach and shows they express KIR3DL1 and TOX.

bioRxiv · Mar 25, 2024 · PreprintImmunology

Tumor-reactive clonotype dynamics underlying clinical response to TIL therapy in melanoma

J. Chiffelle, D. Barras, R. Petremand, A. Orcurto, S. Bobisse, M. Arnaud, A. Auger, B. Navarro Rodrigo, E. Ghisoni, C. Sauvage, D. Saugy, A. Michel, B. Murgues, N. Fahr, M. Imbimbo, , G. Coukos

This study tracks tumor-reactive TIL clonotypes in melanoma patients before and after TIL-ACT to identify factors associated with clinical response.

bioRxiv · Jul 21, 2023 · PreprintCancer Biology

TCRpcDist: Estimating TCR physico-chemical similarity to analyze repertoires and predict specificities

M. A. S. Perez Gomes, J. Chiffelle, S. Bobisse, F. Mayol-Rullan, M. Arnaud, C. Sauvage, G. Coukos, A. Harari, V. Zoete

TCRpcDist clusters TCR repertoires based on physico-chemical properties to predict antigen specificity and identify TCR groups likely to bind similar epitopes.

bioRxiv · Jun 15, 2023Immunology

Tumor Microenvironment Cellular Crosstalk Predicts Response to Adoptive TIL Therapy in Melanoma

D. Barras, E. Ghisoni, J. Chiffelle, A. Orcurto, J. Dagher, N. Fahr, F. Benedetti, I. Crespo, S. Zimmermann, R. Duran, M. Imbimbo, M. Ochoa De Olza, B. Navarro, K. Homiscko, S. Bobisse, , G. Coukos

This study identifies CD8+ TIL-myeloid cell networks as predictors of response to adoptive TIL therapy in melanoma using single-cell RNA-seq and spatial proteomic analyses.

bioRxiv · Dec 23, 2022 · PreprintImmunology

Deep motif deconvolution of HLA-II peptidomes for robust class II epitope predictions

J. Racle, J. Michaux, G. A. Rockinger, M. Arnaud, S. Bobisse, C. Chong, P. Guillaume, G. Coukos, A. Harari, C. Jandus, M. Bassani-Sternberg, D. Gfeller

The paper improves HLA-II epitope prediction by combining mass spectrometry data with a new motif deconvolution algorithm, enhancing motif definition and prediction accuracy.

bioRxiv · Feb 3, 2019Immunology